Affordable Access

Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)

Authors
Journal
Drug Discovery Today
1359-6446
Publisher
Elsevier
Volume
17
Identifiers
DOI: 10.1016/j.drudis.2011.12.010
Disciplines
  • Pharmacology
  • Political Science

Abstract

The effort to repurpose old drugs for new uses is not sufficient; even drugs that have been used clinically for decades must undergo expensive clinical trials. This process requires the pharmaceutical industry to fund the repatenting of old drugs. Because inexpensive drugs are necessary for people around the world, attempts should be made to develop nonprofit drugs through clinical trials of generic drugs that are funded by governments and charities. Evidence supports the use the old anti-alcoholic drug Antabuse as a new nonprofit drug for cancer.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments